Clinical Trials Directory

Trials / Completed

CompletedNCT07428603

Extrinsic Tooth Whitening Evaluation of a Whitening Toothpaste

Six-Week Clinical Evaluation of a Toothpaste in Tooth Whitening Via Extrinsic Stain Removal

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
118 (actual)
Sponsor
Church & Dwight Company, Inc. · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This randomized, examiner-blind, parallel-group clinical study evaluated the effectiveness of a whitening toothpaste compared with a control toothpaste in removing extrinsic tooth stain over six weeks of twice-daily unsupervised use. Adult subjects were assessed at baseline and after 7, 14, 28, and 42 days of product use using the Macpherson Modification of the Lobene Stain Index. Oral soft and hard tissues and subject-reported sensory responses were also evaluated throughout the study.

Detailed description

This single-site, randomized, examiner-blind, two-cell parallel clinical trial enrolled adult subjects with qualifying extrinsic tooth stain. Following baseline assessments, subjects were randomized to either a test whitening dentifrice or a marketed control dentifrice. Subjects brushed twice daily for two minutes with their assigned toothpaste and toothbrush for 42 days. Extrinsic stain on the labial surfaces of the 12 anterior teeth was evaluated at baseline and at Days 7, 14, 28, and 42 using the Macpherson Modification of the Lobene Stain Index, assessing stain intensity, stain area, and total stain scores. Safety was monitored via oral soft and hard tissue examinations and subject-reported sensory assessments. Treatment comparisons were performed using ANCOVA with baseline scores as covariates.

Conditions

Interventions

TypeNameDescription
OTHERWhitening Test Dentifrice (Code 826)Whitening toothpaste used twice daily for two minutes per brushing for six weeks.
OTHERControl dentifrice (Code 378)Non-whitening toothpaste used twice daily for two minutes per brushing for six weeks.

Timeline

Start date
2024-08-08
Primary completion
2024-09-20
Completion
2024-09-20
First posted
2026-02-24
Last updated
2026-02-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07428603. Inclusion in this directory is not an endorsement.